PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

2167 Resources
2167 Resources
2167 Resources
    Date
    From
    To
  1. PATH has been contributing to Nepal's healthcare transformation since 2014. PATH partners with governments and local organizations to strengthen health systems by addressing inequities in key health areas—vaccines and immunization, neglected tropical diseases, digital health, maternal, new born, child health and nutrition and disease surveillance.
    Published: March 2023
    Resource Page
    Brief
  2. PATH works to strengthen health equity through increased access to gender-responsive health services and innovations. Read this factsheet to learn more about our work in this area.
    Published: March 2023
    Resource Page
    Fact Sheet
  3. The Global Fund to Fight AIDS, Tuberculosis and Malaria is a worldwide movement to defeat HIV, tuberculosis (TB), and malaria and ensure a healthier, safer, more equitable future for all. They raise and invest US$4 billion a year to fight the deadliest infectious diseases, challenge the injustice that fuels them, and strengthen health systems in more than 100 countries. In recent years, the Global Fund has emerged as an important source of funding for respiratory care equipment, supplies, and services for low- and middle-income countries—with the COVID-19 Response Mechanism (C19RM), and more recently, via the inclusion of respiratory care equipment as a new allowable Resilient and Sustainable Systems for Health (RSSH) intervention.This brief outlines key information and resources for pursuing funding for oxygen and respiratory care systems through the Global Fund via the C19RM and country grants. It is intended for use by applicants, partners, civil society, and others in developing funding requests and/or advocating for prioritization of respiratory care goods and services in Global Fund grants.
    Published: March 2023
    Resource Page
    Brief
  4. PATH initiated an intervention study, A Mixed-Method Study to Improve the Outcome of Mass Drug Administration in Two Districts of Uttar Pradesh That Failed the Transmission Assessment Survey. The study aims to identify the critical factors for achieving optimal drug coverage amongst community members during mass drug administration (MDA) campaigns, develop an intervention package for use in the government’s subsequent MDA programme to improve compliance, and assess the impact of the intervention package on drug coverage.The study was conducted in the districts of Varanasi and Chitrakoot in Uttar Pradesh, as they failed Transmission Assessment Surveys (TASs), have suboptimal health indicators, and are geographically and demographically representative of districts that are lymphatic filariasis (LF) endemic in the country.The report shares the key findings and assesses the impact of the intervention package on reach and consumption of LF drugs during MDA rounds.
    Published: March 2023
    Resource Page
    Report
  5. Japanese encephalitis (JE) is the leading viral cause of disability in Asia. The mosquitoes that transmit JE breed in areas of standing water, such as rice paddies, making rural communities of Asia particularly vulnerable. Immunization is the best method to prevent JE, but control efforts have been hindered by inadequate disease surveillance, limited/unstable vaccine supply, variable guidance and programmatic support, and competing country/state priorities. Over the past several years, focused efforts from PATH and other partners have improved the landscape of JE control across the country.In 2006, the government launched the Japanese Encephalitis Vaccine (JEV) campaign, rolling out a successful program within eight months. Over nine million children were able to receive JEV ahead of the JE season in India. This proved to be a landmark year for India’s rural population after decades of suffering from recurring JE outbreaks.This document details the phased JEV campaign across select endemic districts of Bihar, followed by the introduction of JEV in the routine immunization schedule and the lessons learned for strengthening immunization program all across.
    Published: March 2023
    Resource Page
    Report